By Andrew Karpan (March 8, 2023, 10:47 PM EST) — Moderna has responded to arguments from a former top federal judge, among other legal academics and pharmaceutical trade organizations that are weighing in on a billion-dollar patent lawsuit over the ownership of the mRNA platform behind one of the COVID-19 vaccines, by asking a federal judge in Delaware to disregard those arguments entirely….